Kok CH - Search Results

1

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.

Noll JE, Vandyke K, Hewett DR, Mrozik KM, Bala RJ, Williams SA, Kok CH, Zannettino AC. Noll JE, et al. Among authors: kok ch. J Hematol Oncol. 2015 Oct 6;8:106. doi: 10.1186/s13045-015-0209-2. J Hematol Oncol. 2015. PMID: 26445238 Free PMC article.

2

SAMSN1 is a tumor suppressor gene in multiple myeloma.

Noll JE, Hewett DR, Williams SA, Vandyke K, Kok C, To LB, Zannettino AC. Noll JE, et al. Neoplasia. 2014 Jul;16(7):572-85. doi: 10.1016/j.neo.2014.07.002. Neoplasia. 2014. PMID: 25117979 Free PMC article.

3

Co-fuse: a new class discovery analysis tool to identify and prioritize recurrent fusion genes from RNA-sequencing data.

Paisitkriangkrai S, Quek K, Nievergall E, Jabbour A, Zannettino A, Kok CH. Paisitkriangkrai S, et al. Among authors: kok ch. Mol Genet Genomics. 2018 Oct;293(5):1217-1229. doi: 10.1007/s00438-018-1454-1. Epub 2018 Jun 7. Mol Genet Genomics. 2018. PMID: 29882166

4

CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre-B-cell acute lymphoblastic leukaemia.

Fitter S, Bradey AL, Kok CH, Noll JE, Wilczek VJ, Venn NC, Law T, Paisitkriangkrai S, Story C, Saunders L, Dalla Pozza L, Marshall GM, White DL, Sutton R, Zannettino ACW, Revesz T. Fitter S, et al. Among authors: kok ch. Br J Haematol. 2021 Apr;193(1):171-175. doi: 10.1111/bjh.17161. Epub 2021 Feb 23. Br J Haematol. 2021. PMID: 33620089

5

The granulocyte-associated transcription factor Krüppel-like factor 5 is silenced by hypermethylation in acute myeloid leukemia.

Diakiw SM, Kok CH, To LB, Lewis ID, Brown AL, D'Andrea RJ. Diakiw SM, et al. Among authors: kok ch. Leuk Res. 2012 Jan;36(1):110-6. doi: 10.1016/j.leukres.2011.09.013. Epub 2011 Oct 11. Leuk Res. 2012. PMID: 21993314

6

Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.

McClure BJ, Heatley SL, Kok CH, Sadras T, An J, Hughes TP, Lock RB, Yeung D, Sutton R, White DL. McClure BJ, et al. Among authors: kok ch. Br J Cancer. 2018 Apr;118(7):1000-1004. doi: 10.1038/s41416-018-0022-0. Epub 2018 Mar 13. Br J Cancer. 2018. PMID: 29531323 Free PMC article.

7

Editorial: Molecular Mechanisms of Multiple Myeloma.

Gozzetti A, Kok CH, Li CF. Gozzetti A, et al. Among authors: kok ch. Front Oncol. 2022 Mar 10;12:870123. doi: 10.3389/fonc.2022.870123. eCollection 2022. Front Oncol. 2022. PMID: 35359371 Free PMC article. No abstract available.

8

Repression of Gadd45alpha by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked differentiation.

Perugini M, Kok CH, Brown AL, Wilkinson CR, Salerno DG, Young SM, Diakiw SM, Lewis ID, Gonda TJ, D'Andrea RJ. Perugini M, et al. Among authors: kok ch. Leukemia. 2009 Apr;23(4):729-38. doi: 10.1038/leu.2008.349. Epub 2009 Jan 8. Leukemia. 2009. PMID: 19151789

9

Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.

Sadras T, Perugini M, Kok CH, Iarossi DG, Heatley SL, Brumatti G, Samuel MS, To LB, Lewis ID, Lopez AF, Ekert PG, Ramshaw HS, D'Andrea RJ. Sadras T, et al. Among authors: kok ch. J Leukoc Biol. 2014 Jul;96(1):83-91. doi: 10.1189/jlb.2AB1013-559R. Epub 2014 Mar 5. J Leukoc Biol. 2014. PMID: 24598054

10

Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines.

Kutyna MM, Loone S, Saunders VA, White DL, Kok CH, Hiwase DK. Kutyna MM, et al. Among authors: kok ch. Int J Mol Sci. 2023 Feb 10;24(4):3553. doi: 10.3390/ijms24043553. Int J Mol Sci. 2023. PMID: 36834962 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters